Cloning from a mouse osteoblastic cell line of a set of transforming‐growth‐factor‐β1‐regulated genes, one of which seems to encode a follistatin‐related polypeptideMotoko Shibanuma, Kiyoshi Nose, Jun‐ichi Mashimo et al.|European Journal of Biochemistry|1993Cited by 275
A phase I pharmacokinetic (PK) study of MBP-426, a novel liposome encapsulated oxaliplatinKamalesh K. Sankhala, Alexandria T. Phan, Akira Mita et al.|Journal of Clinical Oncology|2009Cited by 82
Phase (Ph) I evaluation of the dolastatin analogue synthadotin (SYN-D; ILX651): Pooled data analysis of three alternate schedules in patients (pts) with advanced solid tumorsL. A. Hammond, Eric K. Rowinsky, Francis Ruvuna et al.|Journal of Clinical Oncology|2004Cited by 8
Pharmacokinetics of synthadotin (ILX651), a novel tubulin polymerization inhibitor, in patients with solid tumorsPeter L. Bonate, L. A. Hammond, Eric H. Rubin et al.|Journal of Clinical Oncology|2004Cited by 2
Phase (Ph) I evaluation of the dolastatin analogue synthadotin (SYN-D; ILX651): Pooled data analysis of three alternate schedules in patients (pts) with advanced solid tumorsL. A. Hammond, Eric K. Rowinsky, F. Ruvuna et al.|Journal of Clinical Oncology|2004Cited by 1